Moderna

Omicron-specific boosters are here: How effective will these vaccines be in the fight against COVID-19?

The new booster shots — one by Moderna and another from Pfizer-BioNTech – are specifically tailored to combat the two most recent and contagious Omicron subvariants, BA4 and BA5

Moderna sues rival vaccine maker Pfizer: Will move affect availibility of COVID-19 vaccine?

Moderna has accused Pfizer and its partner BioNTech of copying its mRNA technology, which it created years before the COVID-19 pandemic

Moderna sues Pfizer, BioNTech for COVID-19 vaccine patent infringement

Pfizer and BioNTech said they have not fully reviewed the complaint, but expressed surprise over the litigation

UK becomes world's first country to approve vaccine against both Omicron & original COVID strain

The 'bivalent' vaccine has been made by US drugmaker Moderna. Notably, in early 2020, the UK became the first country to roll out a COVID vaccination drive

Novel COVID-19 vaccine offers superior protection against Omicron variants

The vaccine, called Omnivax, increases neutralising antibody response against the BA.1 and BA.2.12.1 Omicron subvariants in pre-immunised mice 19-fold and eight-fold, respectively, compared with standard mRNA vaccines

FDA authorizes first COVID-19 shots for infants, preschoolers; vaccinations to begin next week

The Food and Drug Administration's action follows its advisory panel's unanimous recommendation for the shots from Moderna and Pfizer. That means US kids under 5, roughly 18 million youngsters, are eligible for the shots

Moderna seeks US authorisation for COVID vaccine in children under 6

Children under six are the only age group that has yet to gain access to a COVID-19 vaccine in the United States and in most countries

Moderna says its low-dose COVID shots work for kids under six

While the study wasn't large enough to detect very rare side effects, Moderna said the small doses were safe and that mild fevers, like those associated with other common pediatric vaccines, were the main reaction

COVID-19: Moderna begins clinical trials of Omicron-specific vaccine booster

This comes a day after rivals Pfizer and BioNTech said they had begun enrollment for a clinical trial for an Omicron-specific vaccine

Moderna CEO says vaccines likely no match for Omicron variant; stock markets sink on comment

Stephane Bancel's warning came as G7 health ministers held emergency talks on the new variant, which is spreading around the world and prompting nations to close their borders once again or impose fresh travel restrictions